These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
156 related articles for article (PubMed ID: 34181461)
1. Vitamin D and lumisterol novel metabolites can inhibit SARS-CoV-2 replication machinery enzymes. Qayyum S; Mohammad T; Slominski RM; Hassan MI; Tuckey RC; Raman C; Slominski AT Am J Physiol Endocrinol Metab; 2021 Aug; 321(2):E246-E251. PubMed ID: 34181461 [TBL] [Abstract][Full Text] [Related]
2. Novel CYP11A1-Derived Vitamin D and Lumisterol Biometabolites for the Management of COVID-19. Qayyum S; Slominski RM; Raman C; Slominski AT Nutrients; 2022 Nov; 14(22):. PubMed ID: 36432468 [TBL] [Abstract][Full Text] [Related]
3. Remdesivir is a direct-acting antiviral that inhibits RNA-dependent RNA polymerase from severe acute respiratory syndrome coronavirus 2 with high potency. Gordon CJ; Tchesnokov EP; Woolner E; Perry JK; Feng JY; Porter DP; Götte M J Biol Chem; 2020 May; 295(20):6785-6797. PubMed ID: 32284326 [TBL] [Abstract][Full Text] [Related]
4. Vitamin D and lumisterol derivatives can act on liver X receptors (LXRs). Slominski AT; Kim TK; Qayyum S; Song Y; Janjetovic Z; Oak ASW; Slominski RM; Raman C; Stefan J; Mier-Aguilar CA; Atigadda V; Crossman DK; Golub A; Bilokin Y; Tang EKY; Chen JY; Tuckey RC; Jetten AM; Song Y Sci Rep; 2021 Apr; 11(1):8002. PubMed ID: 33850196 [TBL] [Abstract][Full Text] [Related]
5. Structure based screening and molecular docking with dynamic simulation of natural secondary metabolites to target RNA-dependent RNA polymerase of five different retroviruses. Azeem M; Mustafa G; Ahmed S; Mushtaq A; Arshad M; Usama M; Farooq M PLoS One; 2024; 19(8):e0307615. PubMed ID: 39102385 [TBL] [Abstract][Full Text] [Related]
6. Photoprotective Properties of Vitamin D and Lumisterol Hydroxyderivatives. Slominski AT; Chaiprasongsuk A; Janjetovic Z; Kim TK; Stefan J; Slominski RM; Hanumanthu VS; Raman C; Qayyum S; Song Y; Song Y; Panich U; Crossman DK; Athar M; Holick MF; Jetten AM; Zmijewski MA; Zmijewski J; Tuckey RC Cell Biochem Biophys; 2020 Jun; 78(2):165-180. PubMed ID: 32441029 [TBL] [Abstract][Full Text] [Related]
7. Selective ability of rat 7-Dehydrocholesterol reductase (DHCR7) to act on some 7-Dehydrocholesterol metabolites but not on lumisterol metabolites. Tuckey RC; Tang EKY; Chen YA; Slominski AT J Steroid Biochem Mol Biol; 2021 Sep; 212():105929. PubMed ID: 34098080 [TBL] [Abstract][Full Text] [Related]
8. In Silico Identification of a Potent Arsenic Based Approved Drug Darinaparsin against SARS-CoV-2: Inhibitor of RNA Dependent RNA polymerase (RdRp) and Essential Proteases. Chowdhury T; Roymahapatra G; Mandal SM Infect Disord Drug Targets; 2021; 21(4):608-618. PubMed ID: 32718300 [TBL] [Abstract][Full Text] [Related]
9. Cyanorona-20: The first potent anti-SARS-CoV-2 agent. Rabie AM Int Immunopharmacol; 2021 Sep; 98():107831. PubMed ID: 34247016 [TBL] [Abstract][Full Text] [Related]
10. A novel virtual screening procedure identifies Pralatrexate as inhibitor of SARS-CoV-2 RdRp and it reduces viral replication in vitro. Zhang H; Yang Y; Li J; Wang M; Saravanan KM; Wei J; Tze-Yang Ng J; Tofazzal Hossain M; Liu M; Zhang H; Ren X; Pan Y; Peng Y; Shi Y; Wan X; Liu Y; Wei Y PLoS Comput Biol; 2020 Dec; 16(12):e1008489. PubMed ID: 33382685 [TBL] [Abstract][Full Text] [Related]
11. Evaluation of the active constituents of Nilavembu Kudineer for viral replication inhibition against SARS-CoV-2: An approach to targeting RNA-dependent RNA polymerase (RdRp). Kuriakose A; Nair B; Abdelgawad MA; Adewum AT; Soliman MES; Mathew B; Nath LR J Food Biochem; 2022 Nov; 46(11):e14367. PubMed ID: 35994404 [TBL] [Abstract][Full Text] [Related]
12. Potential Candidates against COVID-19 Targeting RNA-Dependent RNA Polymerase: A Comprehensive Review. Agrawal N; Goyal A Curr Pharm Biotechnol; 2022; 23(3):396-419. PubMed ID: 33882805 [TBL] [Abstract][Full Text] [Related]
13. SARS-CoV-2 RNA polymerase as target for antiviral therapy. Buonaguro L; Tagliamonte M; Tornesello ML; Buonaguro FM J Transl Med; 2020 May; 18(1):185. PubMed ID: 32370758 [TBL] [Abstract][Full Text] [Related]
14. Structural basis for inhibition of the RNA-dependent RNA polymerase from SARS-CoV-2 by remdesivir. Yin W; Mao C; Luan X; Shen DD; Shen Q; Su H; Wang X; Zhou F; Zhao W; Gao M; Chang S; Xie YC; Tian G; Jiang HW; Tao SC; Shen J; Jiang Y; Jiang H; Xu Y; Zhang S; Zhang Y; Xu HE Science; 2020 Jun; 368(6498):1499-1504. PubMed ID: 32358203 [TBL] [Abstract][Full Text] [Related]
16. Discovery of Potent SARS-CoV-2 Inhibitors from Approved Antiviral Drugs via Docking and Virtual Screening. Chtita S; Belhassan A; Aouidate A; Belaidi S; Bouachrine M; Lakhlifi T Comb Chem High Throughput Screen; 2021; 24(3):441-454. PubMed ID: 32748740 [TBL] [Abstract][Full Text] [Related]
17. Protective effects of novel derivatives of vitamin D Chaiprasongsuk A; Janjetovic Z; Kim TK; Jarrett SG; D'Orazio JA; Holick MF; Tang EKY; Tuckey RC; Panich U; Li W; Slominski AT Redox Biol; 2019 Jun; 24():101206. PubMed ID: 31039479 [TBL] [Abstract][Full Text] [Related]
18. Analysis of SARS-CoV-2 RNA-dependent RNA polymerase as a potential therapeutic drug target using a computational approach. Aftab SO; Ghouri MZ; Masood MU; Haider Z; Khan Z; Ahmad A; Munawar N J Transl Med; 2020 Jul; 18(1):275. PubMed ID: 32635935 [TBL] [Abstract][Full Text] [Related]
19. Cordycepin as a Promising Inhibitor of SARS-CoV-2 RNA Dependent RNA Polymerase (RdRp). Bibi S; Hasan MM; Wang YB; Papadakos SP; Yu H Curr Med Chem; 2022; 29(1):152-162. PubMed ID: 34420502 [TBL] [Abstract][Full Text] [Related]
20. Identifying SARS-CoV-2 antiviral compounds by screening for small molecule inhibitors of nsp12/7/8 RNA-dependent RNA polymerase. Bertolin AP; Weissmann F; Zeng J; Posse V; Milligan JC; Canal B; Ulferts R; Wu M; Drury LS; Howell M; Beale R; Diffley JFX Biochem J; 2021 Jul; 478(13):2425-2443. PubMed ID: 34198323 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]